The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes

HJ Woerle, L Carneiro, A Derani, B Göke, J Schirra - Diabetes, 2012 - Am Diabetes Assoc
HJ Woerle, L Carneiro, A Derani, B Göke, J Schirra
Diabetes, 2012Am Diabetes Assoc
In order to quantify the role of incretins in first-and second-phase insulin secretion (ISR) in
type 2 diabetes mellitus (T2DM), a double-blind, randomized study with 12 T2DM subjects
and 12 healthy subjects (HS) was conducted using the hyperglycemic clamp technique
together with duodenal nutrition perfusion and intravenous infusion of the glucagon-like
peptide 1 (GLP-1) receptor antagonist exendin (9-39). Intravenous glucose alone resulted in
a significantly greater first-and second-phase ISR in HS compared with T2DM subjects …
In order to quantify the role of incretins in first- and second-phase insulin secretion (ISR) in type 2 diabetes mellitus (T2DM), a double-blind, randomized study with 12 T2DM subjects and 12 healthy subjects (HS) was conducted using the hyperglycemic clamp technique together with duodenal nutrition perfusion and intravenous infusion of the glucagon-like peptide 1 (GLP-1) receptor antagonist exendin(9-39). Intravenous glucose alone resulted in a significantly greater first- and second-phase ISR in HS compared with T2DM subjects. Duodenal nutrition perfusion augmented both first- and second-phase ISR but first-phase ISR more in T2DM subjects (approximately eight- vs. twofold). Glucose-related stimulation of ISR contributed only 20% to overall ISR. Infusion with exendin(9-39) significantly reduced first- and second-phase ISR in both HS and T2DM subjects. Thus, both GLP-1 and non–GLP-1 incretins contribute to the incretin effect. In conclusion, both phases of ISR are impaired in T2DM. In particular, the responsiveness to glucose in first-phase ISR is blunted. GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) secretions are unaltered. The absolute incretin effect is reduced in T2DM; its relative importance, however, appears to be increased, highlighting its role as an important amplifier of first-phase ISR in T2DM.
Am Diabetes Assoc